Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

NCT01230385 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Lersivirine
DRUG: Lersivirine
DRUG: Lersivirine
DRUG: Lersivirine
DRUG: Lersivirine

Sponsor

Pfizer

Collaborators

[object Object]